PharmiWeb.com - Global Pharma News & Resources
22-Feb-2019

Bipolar Disorder Market To Rise At A Steady Growth Rate In The Coming Years

Bipolar Disorder, also known as manic depression, is a brain disorder that causes unusual changes in person’s mood, ability to function, and energy levels. People suffering from bipolar disorders have extreme and intense emotional states that occur at different times, called mood episodes. People with bipolar disorder have instants in which they feel very happy and energized and sometimes feel very sad, sluggish, and hopeless.

Technological advancements that facilitate accurate detection of patient’s mood and mental state and growing government initiatives for creating awareness about bipolar disorders are key factors driving growth of the global bipolar disorder market. In addition, increasing incidence of bipolar disorders across the globe is a major factor expected to fuel growth to the global bipolar disorder market over forecast period.

However, many of the drugs used in treatment of bipolar disorders have associated side effects such as blurred vision, damage to the liver, thyroid disorders, etc. This is a key factor restraining growth of the global bipolar disorder market. Additionally, stringent government regulations on drug manufacturing and misdiagnosis of bipolar disorder are major factors expected to hamper growth of the global bipolar diagnostics market over the forecast period.

The global bipolar disorder market is segmented on the basis of type, drug class, mechanism of action, and region. On the basis of region, into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America is a dominant player in the global bipolar disorder market and accounts for highest market share in terms of revenue as compared to that of markets in other regions. This is attributed to increasing government initiatives for creating awareness about bipolar disorders and availability of treatment options in the region. Europe accounts for the second highest revenue share contribution to the global bipolar disorder market. The market in Asia Pacific is projected to have the fastest growth in terms of CAGR, owing to increasing awareness about mental illnesses in the region.

Get Free Sample Copy Of This Research @ https://marketresearch.biz/report/bipolar-disorder-market/request-sample/

Prominent players in the global bipolar disorder market include Otsuka America Pharmaceutical, Inc., Pfizer Inc., GlaxoSmithKline plc., Janssen Pharmaceuticals, Inc., Eli Lilly and Company, Allergan, Abbott, Bristol-Myers Squibb Company, AstraZeneca, and Sumitomo Dainippon Pharma Co., Ltd.

What does this report deliver?
1. Comprehensive analysis of global as well as regional markets.
2. Complete coverage of all the segments of the market to analyze the trends, developments in the worldwide market and forecast of market size up to 2028.
3. Comprehensive analysis of the companies operating globally. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

In short, we are of the conclusion that the global market report provides thorough data for the key players, to clearly understand market deeply. Outstanding players influencing the market through production cost, revenue, share, market size, growth rate, by regional revenue, are enclosed in this report along with the market growth strategies. The report primarily helps to realize and learn the most prohibiting and poignant driving forces of market with anticipating the impacts on the global market.

Editor Details

Last Updated: 22-Feb-2019